Abstract:Purpose: N 6 -methyladenosine (m 6 A) mRNA methylation is affected by dietary factors and associated with lipid metabolism; however, whether the regulatory role of resveratrol in lipid metabolism is involved in m 6 A mRNA methylation remains unknown. Here, the objective of this study was to investigate the effect of resveratrol on hepatic lipid metabolism and m 6 A RNA methylation in the liver of mice. Methods: A total of 24 male mice were randomly allocated to LFD (low-fat diet), LFDR (low-fat diet + resveratrol), HFD (high-fat diet), and HFDR (high-fat diet + resveratrol) groups for 12 weeks ( n = 6/group). Final body weight of mice was measured before sacrificing. Perirhemtric fat, abdominal and epididymal fat, liver tissues, and serum were collected at sacrifice and analyzed. Briefly, mice phenotype, lipid metabolic index, and m 6 A modification in the liver were assessed. Results: Compared to the HFD group, dietary resveratrol supplementation reduced the body weight and relative abdominal, epididymal, and perirhemtric fat weight in high-fat-exposed mice; however, resveratrol significantly increased average daily feed intake in mice given HFD. The amounts of serum low-density lipoprotein cholesterol (LDL), liver total cholesterol (TC), and triacylglycerol (TAG) were significantly decreased by resveratrol supplementation. In addition, resveratrol significantly enhanced the levels of peroxisome proliferator-activated receptor alpha ( PPARα ), peroxisome proliferator-activated receptor beta/delta ( PPARβ/δ ), cytochrome P450, family 4, subfamily a, polypeptide 10/14 ( CYP4A10 / 14 ), acyl-CoA oxidase 1 ( ACOX1 ), and fatty acid-binding protein 4 ( FABP4 ) mRNA and inhibited acyl-CoA carboxylase ( ACC ) mRNA levels in the liver. Furthermore, the resveratrol in HFD increased the transcript levels of methyltransferase like 3 ( METTL3 ), alkB homolog 5 ( ALKBH5 ), fat mass and obesity associated protein ( FTO ), and YTH domain family 2 ( YTHDF2 ), whereas it decreased the level of YTH domain family 3 ( YTHDF3 ) and m 6 A abundance in mice liver. Conclusion: The beneficial effect of resveratrol on lipid metabolism disorder under HFD may be due to decrease of m 6 A RNA methylation and increase of PPARα mRNA, providing mechanistic insights into the function of resveratrol in alleviating the disturbance of lipid metabolism in mice.

Effects of Resveratrol on Gut Microbiota and Fat Storage in A Mouse Model with High-Fat-Induced Obesity

Resveratrol-induced Gut Microbiota Reduces Obesity in High-Fat Diet-Fed Mice.

Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota

Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice.

Gut Microbiota Composition in Relation to the Metabolism of Oral Administrated Resveratrol

Resveratrol exerts anti-obesity effects while browning the inguinal white adipose tissue

Targeting the Gut Microbiota with Resveratrol: a Demonstration of Novel Evidence for the Management of Hepatic Steatosis.

Effects of Resveratrol on Redox State of Adipose Tissue and Lipid of Mice Fed with High-fat Diet

Regulatory Effects of Resveratrol on Glucose Metabolism and T-Lymphocyte Subsets in the Development of High-Fat Diet-Induced Obesity in C57bl/6 Mice

Protective Effects of Dietary Resveratrol against Chronic Low-Grade Inflammation Mediated through the Gut Microbiota in High-Fat Diet Mice

Effects of resveratrol on high-fat diet-induced hypertrophic obesity in elderly mice

Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats

Resveratrol reduces the inflammatory response in adipose tissue and improves adipose insulin signaling in high-fat diet-fed mice.

Resveratrol Prevents Suppression of Regulatory T-cell Production, Oxidative Stress, and Inflammation of Mice Prone or Resistant to High-Fat Diet–induced Obesity

Resveratrol Regulates Relevant Genes to Promote Excretions of Total Sterols in Long-Term Hf Fed C57bl/6j Mice

Resveratrol inhibits white adipose deposition by the ESR1-mediated PI3K/AKT signaling pathway

Resveratrol Derivative BTM-0512 Mitigates Obesity by Promoting Beige Remodeling of Subcutaneous Preadipocytes

Effects of Resveratrol on Lipid Metabolism in C57BL/6J Mice

Resveratrol Attenuates High-Fat Diet Induced Hepatic Lipid Homeostasis Disorder and Decreases m6A RNA Methylation

Resveratrol Inhibits the Formation and Accumulation of Lipid Droplets Through AdipoQ Signal Pathway and Lipid Metabolism Lncrnas

Effects of aerobic exercising and resveratrol on the adiponectin receptors and downstream signaling pathways of obese rats